NIOX Group (LON:NIOX) Stock Price Down 2.3% – Time to Sell?

NIOX Group Plc (LON:NIOX) fell 2.3% during trading on Wednesday . The company traded as low as GBX 59 ($0.73) and last traded at GBX 60 ($0.74). 260,541 shares traded hands during mid-day trading, a decline of 32% from the average session volume of 384,684 shares. The stock had previously closed at GBX 61.40 ($0.76).

NIOX Group Stock Performance

The company has a quick ratio of 1.94, a current ratio of 6.32 and a debt-to-equity ratio of 1.10. The firm has a 50-day moving average of GBX 62.85 and a 200 day moving average of GBX 64.94. The stock has a market capitalization of £254.48 million, a P/E ratio of 3,000.00 and a beta of 0.92.

Insider Transactions at NIOX Group

In related news, insider Jonathan Emms bought 31,604 shares of the company’s stock in a transaction dated Wednesday, December 18th. The stock was acquired at an average cost of GBX 63 ($0.78) per share, with a total value of £19,910.52 ($24,611.27). Also, insider Garry Watts sold 27,109 shares of the firm’s stock in a transaction that occurred on Friday, October 25th. The stock was sold at an average price of GBX 80 ($0.99), for a total value of £21,687.20 ($26,807.42). 46.72% of the stock is owned by insiders.

About NIOX Group

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients.